Rapamycin has been shown to mitigate mTOR hyperactivity, even in a diet-induced insulin resistance scenario [365,367,368]; furthermore, the induction of insulin resistance and mTOR hyperactivation exacerbate cognitive decline and AD pathogenesis [369]. Here, MTOR is linked to Insulin resistance.